Combined Delivery of Temozolomide and siPLK1 Using Targeted Nanoparticles to Enhance Temozolomide Sensitivity in Glioma
Hui Shi et al, 2020, International Journal of Nanomedicine CrossRef
Nose-to-Brain Delivery of Antioxidants as a Potential Tool for the Therapy of Neurological Diseases Maria Cristina Bonferoni et al, 2020, Pharmaceutics CrossRef
Valproic acid disables the Nrf2 anti-oxidant response in acute myeloid leukaemia cells enhancing reactive oxygen species-mediated killing Yao Jiang et al, 2022, British Journal of Cancer CrossRef
Exploring the role of Nrf2 signaling in glioblastoma multiforme Wireko Andrew Awuah et al, 2022, Discover Oncology CrossRef
HJ22, a Novel derivative of piperine, Attenuates ibotenic acid-induced cognitive impairment, oxidativestress, apoptosis and inflammation via inhibiting the protein-protein interaction of Keap1-Nrf2 Xiping Yang et al, 2020, International Immunopharmacology CrossRef
Temozolomide hexadecyl ester targeted plga nanoparticles for drug-resistant glioblastoma therapy via intranasal administration Siqi Wang et al, 2022, Frontiers in Pharmacology CrossRef
Melatonin Induces Melanogenesis in Human SK-MEL-1 Melanoma Cells Involving Glycogen Synthase Kinase-3 and Reactive Oxygen Species Juan Perdomo et al, 2020, International Journal of Molecular Sciences CrossRef
Temozolomide Resistance in Glioblastoma by NRF2: Protecting the Evil Karoline Almeida Lima et al, 2023, Biomedicines CrossRef
Melatonin’s Antineoplastic Potential Against Glioblastoma Enrico Moretti et al, 2020, Cells CrossRef
Rational design of siRNA-based delivery systems for effective treatment of brain diseases Dailin Lu et al, 2024, Pharmaceutical Science Advances CrossRef
Increased Nose-to-Brain Delivery of Melatonin Mediated by Polycaprolactone Nanoparticles for the Treatment of Glioblastoma Edilson Ribeiro de Oliveira Junior et al, 2019, Pharmaceutical Research CrossRef
The association between NRF2 transcriptional gene dysregulation and IDH mutation in Grade 4 astrocytoma Maher Kurdi et al, 2023, Oncologie CrossRef
Hemin-induced platelet activation and ferroptosis is mediated through ROS-driven proteasomal activity and inflammasome activation: Protection by Melatonin Somanathapura K. NaveenKumar et al, 2019, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease CrossRef
The Role of NRF2/KEAP1 Pathway in Glioblastoma: Pharmacological Implications Seyed Hossein Shahcheraghi et al, 2022, Medical Oncology CrossRef